BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 16388995)

  • 1. A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma.
    Xue YJ; Liu J; Pursley J; Unger S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):213-22. PubMed ID: 16388995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma.
    Xue YJ; Liu J; Unger S
    J Pharm Biomed Anal; 2006 Jun; 41(3):979-88. PubMed ID: 16533587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/mass spectrometry for the quantitation of muraglitazar in monkey plasma.
    Yao M; Srinivas N
    Biomed Chromatogr; 2006 Oct; 20(10):1017-23. PubMed ID: 16506266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple 96-well liquid-liquid extraction with a mixture of acetonitrile and methyl t-butyl ether for the determination of a drug in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold ME
    J Pharm Biomed Anal; 2004 Feb; 34(2):369-78. PubMed ID: 15013151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of eprosartan in human plasma and urine by LC/MS/MS.
    Li XN; Xu HR; Chen WL; Liu GY; Chu NN; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):47-53. PubMed ID: 17409033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of chiglitazar, a dual alpha/gamma peroxisome proliferator-activated receptor (PPAR) agonist, in human plasma by liquid chromatography-tandem mass spectrometry.
    Chu NN; Li XN; Chen WL; Xu HR
    Pharmazie; 2007 Nov; 62(11):825-9. PubMed ID: 18065097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
    Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
    J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format.
    Wen J; Wu Y; Zhang L; Qi Y; Fan G; Wu Y; Li Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):153-9. PubMed ID: 18407809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated 96-well solid phase extraction and hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of cetirizine (ZYRTEC) in human plasma--with emphasis on method ruggedness.
    Song Q; Junga H; Tang Y; Li AC; Addison T; McCort-Tipton M; Beato B; Naidong W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):105-14. PubMed ID: 15607714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Yamane N; Tozuka Z; Sugiyama Y; Tanimoto T; Yamazaki A; Kumagai Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):118-28. PubMed ID: 17804306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection.
    Vlase L; Imre S; Muntean D; Leucuta SE
    J Pharm Biomed Anal; 2007 Jul; 44(3):652-7. PubMed ID: 16962733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma.
    Zhang X; Zhao M; Rudek MA; He P; Vogelstein B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):217-22. PubMed ID: 17307035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of chlorpyrifos and its metabolites in rat brain tissue using coupled-column liquid chromatography/electrospray ionization tandem mass spectrometry.
    Williamson LN; Terry AV; Bartlett MG
    Rapid Commun Mass Spectrom; 2006; 20(18):2689-95. PubMed ID: 16912982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma.
    Li W; Rettig J; Jiang X; Francisco DT; Naidong W
    Biomed Chromatogr; 2006 Nov; 20(11):1242-51. PubMed ID: 16838265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of glycyrrhizin, a marker component in radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC-MS/MS.
    Lin ZJ; Qiu SX; Wufuer A; Shum L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):201-7. PubMed ID: 15639440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC/ESI-MS method for the determination of trimetazidine in human plasma: application to a bioequivalence study on Chinese volunteers.
    Jiao Y; Su M; Chen M; Jia W; Chou Y; Huang Z; Yang N; Tong W
    J Pharm Biomed Anal; 2007 Apr; 43(5):1804-7. PubMed ID: 17208404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.